The Global Animal Intestinal Health Market was valued at USD 4.5 billion in 2024 and is estimated to grow at a CAGR of 8.3% to reach USD 9.8 billion by 2034 due to a surge in gastrointestinal conditions among animals, including chronic digestive disorders and inflammation-related issues. With growing concerns around animal wellness, the demand for preventive care is accelerating, especially in livestock management. Maintaining optimal gut health has become a crucial factor not just for disease prevention but also for improving feed efficiency and overall animal productivity. As meat, dairy, and egg consumption continues to rise globally, particularly in fast-developing economies, demand for healthy livestock has become more urgent and commercially important.
As global agricultural practices shift away from antibiotic-heavy treatments, natural alternatives such as probiotics and prebiotics are gaining substantial momentum. These nutritional supplements offer sustainable solutions for maintaining digestive balance and immune performance in animals. The market also reflects a growing interest in holistic, non-therapeutic approaches to animal husbandry. Digestive health, now viewed as central to the economic and biological performance of livestock and companion animals alike, is driving innovation and product development across nutritional and pharmaceutical segments.
Based on product category, nutrition-based solutions held the largest share in 2024, generating USD 2.9 billion in revenue. This growth stems from increasing awareness among farmers, pet owners, and veterinarians about the value of balanced diets and gut-supporting nutrients. Preventive approaches are becoming more popular as they reduce the dependency on drug-based treatments. Companies have ramped up efforts to educate stakeholders on the long-term benefits of dietary supplementation, encouraging greater adoption of gut health enhancers in both commercial farms and homes.
Livestock animals represent the leading segment by animal type are projected to generate USD 5.6 billion by 2034. This segment includes cattle, poultry, and swine integral to the global protein supply. Healthy intestinal function in livestock ensures higher productivity, improved immune response, and reduced mortality, making gut health management a key part of efficient farming. As consumer demand for meat and dairy continues to climb, maintaining intestinal well-being in livestock becomes essential to sustaining food security and economic stability.
United States Animal Intestinal Health Market generated USD 1.6 billion in 2024, driven by increasing consumer awareness about pet health, a surge in companion animal adoption, and the growing emphasis on preventive veterinary care. The steady rise in pet ownership across the country is a key factor contributing to the expansion of the market. More households treat pets as family members, spending on their wellness and nutrition. With intestinal health playing a vital role in the overall well-being and longevity of animals, pet owners are becoming more proactive in choosing gut-supportive diets, supplements, and functional products.
Key players in the market include AdvaCarePharma, Evonik, Lallemand, Zoetis, Kerry Group, Phibro Animal Health, Kemin, Cargill, ADM, Koninklijke DSM, PetAg, Adisseo, Karyotica Biologicals, PRN Pharmacal, and BioChem. These companies are investing in targeted R&D for developing advanced prebiotics, synbiotics, and gut-boosting enzymes. Many are expanding their global presence through partnerships and strategic acquisitions, while also launching awareness campaigns to promote early adoption of preventive gut health solutions in animals.
This product will be delivered within 2-4 business days.
As global agricultural practices shift away from antibiotic-heavy treatments, natural alternatives such as probiotics and prebiotics are gaining substantial momentum. These nutritional supplements offer sustainable solutions for maintaining digestive balance and immune performance in animals. The market also reflects a growing interest in holistic, non-therapeutic approaches to animal husbandry. Digestive health, now viewed as central to the economic and biological performance of livestock and companion animals alike, is driving innovation and product development across nutritional and pharmaceutical segments.
Based on product category, nutrition-based solutions held the largest share in 2024, generating USD 2.9 billion in revenue. This growth stems from increasing awareness among farmers, pet owners, and veterinarians about the value of balanced diets and gut-supporting nutrients. Preventive approaches are becoming more popular as they reduce the dependency on drug-based treatments. Companies have ramped up efforts to educate stakeholders on the long-term benefits of dietary supplementation, encouraging greater adoption of gut health enhancers in both commercial farms and homes.
Livestock animals represent the leading segment by animal type are projected to generate USD 5.6 billion by 2034. This segment includes cattle, poultry, and swine integral to the global protein supply. Healthy intestinal function in livestock ensures higher productivity, improved immune response, and reduced mortality, making gut health management a key part of efficient farming. As consumer demand for meat and dairy continues to climb, maintaining intestinal well-being in livestock becomes essential to sustaining food security and economic stability.
United States Animal Intestinal Health Market generated USD 1.6 billion in 2024, driven by increasing consumer awareness about pet health, a surge in companion animal adoption, and the growing emphasis on preventive veterinary care. The steady rise in pet ownership across the country is a key factor contributing to the expansion of the market. More households treat pets as family members, spending on their wellness and nutrition. With intestinal health playing a vital role in the overall well-being and longevity of animals, pet owners are becoming more proactive in choosing gut-supportive diets, supplements, and functional products.
Key players in the market include AdvaCarePharma, Evonik, Lallemand, Zoetis, Kerry Group, Phibro Animal Health, Kemin, Cargill, ADM, Koninklijke DSM, PetAg, Adisseo, Karyotica Biologicals, PRN Pharmacal, and BioChem. These companies are investing in targeted R&D for developing advanced prebiotics, synbiotics, and gut-boosting enzymes. Many are expanding their global presence through partnerships and strategic acquisitions, while also launching awareness campaigns to promote early adoption of preventive gut health solutions in animals.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Animal Type, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Function, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Mode of Administration, 2021-2034 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Distribution Channel, 2021-2034 ($ Mn)
Chapter 10 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 11 Company Profiles
Companies Mentioned
The companies featured in this Animal Intestinal Health market report include:- Adisseo
- ADM
- AdvaCarePharma
- BioChem
- Cargill
- Evonik
- Karyotica Biologicals
- Kemin
- Kerry Group
- Koninklijke DSM
- Lallemand
- PetAg
- Phibro Animal Health
- PRN Pharmacal
- Zoetis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | May 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 4.5 Billion |
| Forecasted Market Value ( USD | $ 9.8 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
